ATEX vs VRTX · P/E 16, rev $6.5M vs P/E 30, rev $3.33B
Anterix Inc (ATEX) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Anterix Inc (ATEX) is a telecom services company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported ATEX revenue for 2026-03-31 was $6.5M. Net income was $90.6M. Revenue was up 7.8% from 2025-03-31 to 2026-03-31. ATEX currently screens at market cap $1.50B and trailing P/E 16.4.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ATEX currently screens at market cap $1.50B and trailing P/E 16.4. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ATEX and VRTX stock pages for the full models.
Not investment advice.